I was kinda hoping Microsoft would improve Activision.
Ask Lemmy
A Fediverse community for open-ended, thought provoking questions
Please don't post about US Politics.
Rules: (interactive)
1) Be nice and; have fun
Doxxing, trolling, sealioning, racism, and toxicity are not welcomed in AskLemmy. Remember what your mother said: if you can't say something nice, don't say anything at all. In addition, the site-wide Lemmy.world terms of service also apply here. Please familiarize yourself with them
2) All posts must end with a '?'
This is sort of like Jeopardy. Please phrase all post titles in the form of a proper question ending with ?
3) No spam
Please do not flood the community with nonsense. Actual suspected spammers will be banned on site. No astroturfing.
4) NSFW is okay, within reason
Just remember to tag posts with either a content warning or a [NSFW] tag. Overtly sexual posts are not allowed, please direct them to either !asklemmyafterdark@lemmy.world or !asklemmynsfw@lemmynsfw.com.
NSFW comments should be restricted to posts tagged [NSFW].
5) This is not a support community.
It is not a place for 'how do I?', type questions.
If you have any questions regarding the site itself or would like to report a community, please direct them to Lemmy.world Support or email info@lemmy.world. For other questions check our partnered communities list, or use the search function.
Reminder: The terms of service apply here too.
Partnered Communities:
Logo design credit goes to: tubbadu
In the development world, Microsoft is actually doing some legitimately good work since the end of the Balmer years. Back then open source was a cancer that needed to be eliminated. Now they have VSCode (maybe the most popular IDE at the moment), develop and release Typescript under an open license, and own github (still a bit of a mixed bag but they're trying).
Narrator: They won't.
Bethesda buying Id Software.
Maybe medical? Like, Bio-Ntech designed the COVID vaccine, Pfizer bought it and could wrap up the phase 3 trials and then scale production?
So, they didn't actually make the product better, but they probably made it viable sooner than if they hadn't bought it?
But that is kind of the normal process for the medical industry at this point..start ups developing new medicine and then shopping it to Big Pharma for buyouts or funding
I don't think we should be too surprised by this. If a company isn't all that good before a conglomerate buys it, then it's unlikely to be widely known. Conversely, if a small company is widely known, it's likely to be exceptionally good. So, even if acquisition usually just results in regression to the mean, we'll still mostly have heard of ones that degraded the company.